Respondents to national online poll from the Synthetic Biology Project are uncertain about potential of gene-editing technology, but a majority support a ban on human-based research.
The Wilson Center’s Synthetic Biology Project today has developed a first-of-its-kind inventory to track products and applications using the emerging technology of synthetic biology.
In a new op-ed, Eleonore Pauwels of the Synthetic Biology Projects and Jim Dratwa explore the limits of what DNA can tell us.
David Shifrin of the Public Library of Science (PLOS) speaks with David Rejeski about the importance of properly communicating synthetic biology concepts.
A cross-disciplinary team is calling for public discussion about a potential new way to solve longstanding global ecological problems by using an emerging technology called “gene drives.”
Environmental scientists and synthetic biologists have for the first time developed a set of key research areas to study the potential ecological impacts of synthetic biology.
In a new set of focus groups convened by the Synthetic Biology Project, participants raised concerns about the specific applications of the emerging technology.
In the new issue of BioCoder, Dr. Todd Kuiken of the Synthetic Biology Project looks at the increased attention being paid to DIYbio in the halls of power in Washington, DC.
The Synthetic Biology Project is working with the OpenPlant Synthetic Biology Research Centre in a new effort to encourage the responsible development of synthetic biology in the United Kingdom.
The Synthetic Biology Project at the Woodrow Wilson International Center for Scholars has been awarded a grant to participate in SYNENERGENE, a newly launched consortium of 28 groups supported with €4 million ($5.3 million) to engage in the responsible governance of synthetic biology.
A first-ever survey of Do-It-Yourself Biology (DIYbio) practitioners by the Synthetic Biology Project finds the community to be far different from fearful and often sensationalist representations in the media.
In a new article, Daniel Grushkin, a fellow with the Synthetic Biology Project, looks at the financial pressures facing the first wave of community labs.